Track topics on Twitter Track topics that are important to you
In another example of companies focused on aging-related diseases, Elevian launched with $5.5 million in seed funding. Elevian’s founders came out of Stanford and then Harvard, focused on regenerati...
Elevian is an emerging biotech company developing medicines that restore youthful regenerative capacity, with the potential to treat and prevent the diseases of aging. Its first target is The post El...
(InSilico Medicine, Inc.) Elevian, a biotech therapeutics company focused on reversing molecular damage caused by aging, and Insilico Medicine, an artificial intelligence (AI) company developing an en...
Denali will collaborate with Sirion in Parkinson’s and Alzheimer’s diseases. Meanwhile, Lundbeck and Elevian unveil drug development partnerships with technology...
Two longevity biotechnology companies partner to discover drugs that target aging On the final day of the largest biotechnology and pharmaceutical partnering week at th...
Insilico Medicine is an artificial intelligence company with R&D offices and resources in the US, Belgium, Russia, the UK, Taiwan, and Korea, sourced through hackathons...
We have published hundreds of Elevian, Inc. news stories on BioPortfolio along with dozens of Elevian, Inc. Clinical Trials and PubMed Articles about Elevian, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Elevian, Inc. Companies in our database. You can also find out about relevant Elevian, Inc. Drugs and Medications on this site too.
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...